Institut Químic De Sarriá CETS Fundació Privada – Trademark Portfolio
Entity Type: 99
Institut Químic De Sarriá CETS Fundació Privada holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include IQS PERSONA CIENCIA EMPRESA and IQS UNIVERSITAT RAMON LLULL. The owner is based in Barcelona.
Vía Augusta, 390
Barcelona 08017 , ES
Showing of trademarks Trademarks
Trademark Classifications
Institut Químic De Sarriá CETS Fundació Privada's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Institut Químic De Sarriá CETS Fundació Privada have?
Institut Químic De Sarriá CETS Fundació Privada has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does Institut Químic De Sarriá CETS Fundació Privada file in?
Institut Químic De Sarriá CETS Fundació Privada files trademarks across 1 Nice Classification class. The most active classes are Class 41 (Education & Entertainment). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Institut Químic De Sarriá CETS Fundació Privada's most well-known trademarks?
Institut Químic De Sarriá CETS Fundació Privada's registered trademark portfolio includes well-known marks such as IQS PERSONA CIENCIA EMPRESA and IQS UNIVERSITAT RAMON LLULL. These are among 2 currently registered trademarks in the portfolio.
What is Institut Químic De Sarriá CETS Fundació Privada's trademark registration success rate?
Institut Químic De Sarriá CETS Fundació Privada has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.